Buprenex 0.3 mg in 1 mL Injection
RxNorm 205533
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 205533 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Buprenex 0.3 mg in 1 mL Injection.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SYPrescribable
Synonym (SY):
1 mL Buprenex 0.3 mg/ML Injection
(Atom ID: 7719807)
SBDPrescribable
Semantic Branded Drug (SBD):
1 mL buprenorphine 0.3 mg/ML Injection [Buprenex]
(Atom ID: 12371641)
PSNPrescribable
Prescribable Name (PSN):
Buprenex 0.3 mg in 1 mL Injection
(Atom ID: 7719806)
SYPrescribable
Synonym (SY):
Buprenex 0.3 mg per 1 mL Injection
(Atom ID: 7719809)
SYPrescribable
Synonym (SY):
Buprenex 0.3 mg/ML (as buprenorphine HCl 0.324 mg/ML) Injection
(Atom ID: 7719808)
Patient Education
Buprenorphine Injection
Buprenorphine extended-release injection is used to treat opioid dependence (addiction to opioid drugs, including heroin and narcotic painkillers) in people who have received buccal or sublingual buprenorphine for at least 7 days. Buprenorphine extended-release injection is in a class of medications called opiate partial agonists. It works to prevent withdrawal symptoms when someone stops taking opioid drugs by producing similar effects to these drugs.
[Learn More]
* Please review the disclaimer below.